Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Quality Index
Guangdong Taienkang Pharmaceutical Co. Ltd cash flow quality index. Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Quality Index of -0.45x as of December 2025. Operating cash flow of CN¥-12.88 Million is below net income of CN¥28.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 301263 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Cash flow quality index of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025. Historical Cash Flow Quality Index for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 301263 equity to assets ratio to measure how much of total assets are equity-financed.
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Quality Index by Year (2019–2025)
Guangdong Taienkang Pharmaceutical Co. Ltd cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Guangdong Taienkang Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of Guangdong Taienkang Pharmaceutical Co. L.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.45x | CN¥-12.88 Million | CN¥28.63 Million | ▼ -154.5% |
| 2024 | 0.83x | CN¥89.33 Million | CN¥108.22 Million | ▲ +41.4% |
| 2023 | 0.58x | CN¥93.53 Million | CN¥160.20 Million | ▼ -31.5% |
| 2022 | 0.85x | CN¥148.81 Million | CN¥174.61 Million | ▼ -14.7% |
| 2021 | 1.00x | CN¥120.02 Million | CN¥120.07 Million | ▲ +28.1% |
| 2020 | 0.78x | CN¥125.53 Million | CN¥160.83 Million | ▼ -43.2% |
| 2019 | 1.37x | CN¥75.44 Million | CN¥54.90 Million | — |